Requires Authentication
An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay
, , , , , , , , , , , , , , , , , and | Mar 31, 2021
About this article
Article Category: article
Published Online: Mar 31, 2021
Page range: 33 - 43
DOI: https://doi.org/10.21307/immunohematology-2021-007
© 2021 A.D. Ho et al., published by Sciendo
A.D. Ho
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
Atlanta,Boston
H. Verkerke
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
Atlanta,Boston
J.W. Allen
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
Atlanta,Boston
B.J. Saeedi
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
D. Boyer
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
J. Owens
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
S. Shin
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
M. Horwath
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
K. Patel
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolBoston, USA
A. Paul
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolBoston, USA
S.-C. Wu
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolBoston, USA
S. Chonat
Department of Pediatrics, Emory University School of MedicineAtlanta, GA
P. Zerra
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
C. Lough
Lifesouth Blood Donation ServicesGainesville, USA
J.D. Roback
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
A. Neish
Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
C.D. Josephson
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
C.M. Arthur
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of MedicineAtlanta, GA
S.R. Stowell
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
Atlanta,Boston